FDA Adverse Event Injury Summary report: N

SET, ADMINISTRATION, FOR PERITONEAL DIALYSIS, DISPOSABLE

MDR report key: 2040463 · Received April 5, 2011

Report

Report Number
1423500-2011-04139
Event Type
Injury
Date Received
April 5, 2011
Date of Event
March 1, 2011
Report Date
March 17, 2011
Manufacturer
BAXTER HEALTHCARE
Product Code
KDJ
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IN
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(4). THE DEVICE INVOLVED IN THE INCIDENT WAS UNKNOWN. AS THE DATE OF ONSET OF THIS PERITONITIS EPISODE IS UNKNOWN AND PATIENTS DISCARD SUPPLIES AFTER EACH THERAPY, THE SAMPLE WAS NOT REQUESTED. A 510(K) NUMBER WILL NOT BE PROVIDED IN THE EMDR AS THE PRODUCT CODE AND LOT NUMBER ARE UNKNOWN. BAXTER HAS RECEIVED SIMILAR REPORTS FOR THE REPORTED PROBLEM. THE ROOT CAUSE INVESTIGATION IS IN PROGRESS.

Description of Event or Problem · 1

THIS REPORT WAS RECEIVED FROM GLOBAL PHARMACOVIGILANCE AND IS A SPONTANEOUS REPORT BY A BAXTER-EMPLOYED NURSE FROM INDIA OF PERITONITIS COINCIDENT WITH DIANEAL PD2 ULTRABAG THERAPY. ON (B)(6) 2011, THE PATIENT BEGAN TREATMENT WITH DIANEAL PD2 ULTRABAG (DOSE AND FREQUENCY NOT REPORTED) INTRAPERITONEALLY (IP) FOR PERITONEAL DIALYSIS (PD). ON (B)(6) 2011, THE PATIENT EXPERIENCED PERITONITIS. THE CAUSE OF THE PERITONITIS WAS UNKNOWN. THE PATIENT WAS NOT HOSPITALIZED. ON (B)(6) 2011, AN EFFLUENT CULTURE AND ANALYSIS WERE PERFORMED. THE RESULTS OF THE CULTURE WERE UNKNOWN AND THE ANALYSES WERE NOT REPORTED. ON (B)(6) 2011, THE PATIENT RECEIVED REMEDIAL TREATMENT WITH A LOADING DOSE OF REFLIN 500 GM ONCE DAILY IP AND ON THE SAME DAY, BEGAN REMEDIAL TREATMENT WITH FORTUM 1 GM ONCE DAILY IP. THE PATIENT WAS RECOVERING FROM THE PERITONITIS. REMEDIAL TREATMENT WITH REFLIN AND FORTUM WAS ONGOING. DIANEAL PD2 ULTRABAG THERAPY WAS ONGOING. THE REPORTER BELIEVED THE EVENT OF PERITONITIS WAS UNRELATED TO DIANEAL PD2 ULTRABAG THERAPY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 SET, ADMINISTRATION, FOR PERITONEAL DIALYSIS, DISPOSABLE KDJ BAXTER HEALTHCARE

Patients

Seq Age Sex Outcome Treatment
1 45 YR Required Intervention DIANEAL PD2 ULTRABAG